Hydrochloric Acid → HCID 66993486, compound

HRID 1877892Notes

Reaction equation

HRID 1877892 reaction equation
C([N:8]1[CH2:14][C:13]2[N:15]=[CH:16][C:17]([N:19]3[CH:23]=[CH:22][N:21]=[C:20]3[CH3:24])=[N:18][C:12]=2[O:11][CH2:10][CH2:9]1)C1C=CC=CC=1.[ClH:25]>CO.[OH-].[OH-].[Pd+2]>[ClH:25].[CH3:24][C:20]1[N:19]([C:17]2[CH:16]=[N:15][C:13]3[CH2:14][NH:8][CH2:9][CH2:10][O:11][C:12]=3[N:18]=2)[CH:23]=[CH:22][N:21]=1

Participants

5

Reactant 2

HCID 313Hydrochloric AcidHCID 66993602HCID 66993602, compound

Product 1

HCID 66993486HCID 66993486, compoundYield 61%

Reagents, catalysts & solvents 2

HCID 9942167Palladium hydroxideCatalystHCID 887MethanolSolvent

Conditions

Temperature
50 °C

Procedure

To a solution of 8-benzyl-3-(2-methyl-1H-imidazol-1-yl)-6,7,8,9-tetrahydropyrazino[2,3-f][1,4]oxazepine (18 mg) in methanol (2.5 mL) was added 20% Pd(OH)2/C (10 mg), and the mixture was stirred under a hydrogen atmosphere at 50° C. for 5 hr. The reaction mixture was filtered, and the filtrate was concentrated. To a solution of the obtained crude product in methanol (0.3 mL) was added 0.1 N hydrochloric acid (410 μL), and the mixture was stirred for 30 min. The reaction mixture was concentrated, and the obtained crystals were purified by recrystallization (methanol-ethyl acetate) to give the title compound (6 mg, 61%) as a pale-yellow powder.

Workup

  1. filtrationThe reaction mixture was filtered
  2. concentrationthe filtrate was concentrated
  3. customTo a solution of the obtained crude product in methanol (0.3 mL)
  4. stirringthe mixture was stirred for 30 min
  5. concentrationThe reaction mixture was concentrated
  6. customthe obtained crystals were purified by recrystallization (methanol-ethyl acetate)

Sources & evidence

ORD record
ord-6de335cd311a48c99df790b77f9f7b1f
Source dataset
uspto-grants-2012_11
Patent number
US08314088B2

Reaction notes

Loading…